Identifying a heart attack and utilizing these life-saving tips will equip you with the knowledge you need to handle a ...

HeartBeam rolled out an application for its 12-lead ECG synthesis software to the FDA, based on the data from the study.

HeartBeam Successfully Meets Clinical Endpoints in Pivotal Study for its Groundbreaking 12-Lead ECG Synthesis Technology ...

HeartBeam (Nasdaq:BEAT) today announced that a study of its synthesized 12-lead electrocardiogram (ECG) met its clinical ...

Sunway Medical Centre Velocity (SMCV) has been officially recognised by the Malaysia Book of Records (MBOR) for the Most ...

At the hospital, she was told an angiogram showed that spasms in her arteries had led to a second heart attack. The 70% ...

Huawei Watch 5 Pro to launch on May 15, and leaks suggest it may feature an upgraded ECG sensor for better heart health ...

Joe got the treatment he needed and now he's a passionate volunteer at the Healthy Heart Project at Henry Ford Providence to ...

The bill was passed in the Florida Senate on Thursday and is now heading to Gov. Ron DeSantis' desk, awaiting his signature.

captures the heart’s electrical signals in three non-coplanar directions. These signals are then synthesized into a 12-lead ECG using a personalized transformation matrix. The technology aims to ...

HeartBeam’s 3D ECG technology, which received FDA clearance for arrhythmia assessment in December 2024, captures the heart’s electrical signals in three non-coplanar directions. These signals are then ...

HeartBeam (NASDAQ: BEAT) announced that its synthesized 12-lead ECG technology met clinical endpoints in the VALID-ECG pivotal study, achieving a 93.